These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17599606)

  • 1. Phenotypic plasticity of sarcomeric protein mutations.
    Marian AJ
    J Am Coll Cardiol; 2007 Jun; 49(25):2427-9. PubMed ID: 17599606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
    Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
    J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Is the True Prevalence of Hypertrophic Cardiomyopathy?
    Baudhuin LM; Kotzer KE; Kluge ML; Maleszewski JJ
    J Am Coll Cardiol; 2015 Oct; 66(16):1845-1846. PubMed ID: 26483113
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetics of restrictive cardiomyopathy.
    Sen-Chowdhry S; Syrris P; McKenna WJ
    Heart Fail Clin; 2010 Apr; 6(2):179-86. PubMed ID: 20347786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moving Beyond the Sarcomere to Explain Heterogeneity in Hypertrophic Cardiomyopathy: JACC Review Topic of the Week.
    Maron BJ; Maron MS; Maron BA; Loscalzo J
    J Am Coll Cardiol; 2019 Apr; 73(15):1978-1986. PubMed ID: 31000001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of de novo variation in pediatric cardiomyopathy.
    Parrott A; Khoury PR; Shikany AR; Lorts A; Villa CR; Miller EM
    Am J Med Genet C Semin Med Genet; 2020 Mar; 184(1):116-123. PubMed ID: 31912959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy.
    Millat G; Bouvagnet P; Chevalier P; Dauphin C; Jouk PS; Da Costa A; Prieur F; Bresson JL; Faivre L; Eicher JC; Chassaing N; Crehalet H; Porcher R; Rodriguez-Lafrasse C; Rousson R
    Eur J Med Genet; 2010; 53(5):261-7. PubMed ID: 20624503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troponin I, cardiac diastolic dysfunction and restrictive cardiomyopathy.
    Huang XP; Du JF
    Acta Pharmacol Sin; 2004 Dec; 25(12):1569-75. PubMed ID: 15569399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recommendations for gene assays for cardiomyopathy in children].
    Subspecialty Group of Cardiology, The Society of Pediatrics, Chinese Medical Association The Editorial Board, Chinese Journal of Pediatrics
    Zhonghua Er Ke Za Zhi; 2013 Aug; 51(8):595-7. PubMed ID: 24225290
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic Restrictive Cardiomyopathy: Causes and Consequences-An Integrative Approach.
    Cimiotti D; Budde H; Hassoun R; Jaquet K
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33429969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant and benign mutations in familial cardiomyopathies: insights into mutations linked to complex cardiovascular phenotypes.
    Xu Q; Dewey S; Nguyen S; Gomes AV
    J Mol Cell Cardiol; 2010 May; 48(5):899-909. PubMed ID: 20298698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mutations in sarcomeric genes MYH7, MYBPC3, TNNT2, TNNI3, and TPM1 in patients with hypertrophic cardiomyopathy].
    García-Castro M; Coto E; Reguero JR; Berrazueta JR; Alvarez V; Alonso B; Sainz R; Martín M; Morís C
    Rev Esp Cardiol; 2009 Jan; 62(1):48-56. PubMed ID: 19150014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sarcomere gene mutations--a cause of hypertrophic cardiomyopathy].
    Kuusisto J; Jääskeläinen P; Laakso M
    Duodecim; 1999; 115(9):997-8. PubMed ID: 11877825
    [No Abstract]   [Full Text] [Related]  

  • 14. Familial hypertrophic cardiomyopathy: a paradigm of the cardiac hypertrophic response to injury.
    Marian AJ; Roberts R
    Ann Med; 1998 Aug; 30 Suppl 1():24-32. PubMed ID: 9800880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcomeric hypertrophic cardiomyopathy: genetic profile in a Portuguese population.
    Brito D; Miltenberger-Miltenyi G; Vale Pereira S; Silva D; Diogo AN; Madeira H
    Rev Port Cardiol; 2012 Sep; 31(9):577-87. PubMed ID: 22857948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabry Disease and/or Hypertrophic Cardiomyopathy.
    Anan R
    Int Heart J; 2017 May; 58(3):305-306. PubMed ID: 28539575
    [No Abstract]   [Full Text] [Related]  

  • 17. SHaRe: advancing the goal of effective treatment for cardiomyopathy.
    Fox JC
    Eur Heart J; 2015 May; 36(19):1142-3. PubMed ID: 26171479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular etiology of idiopathic cardiomyopathy in Asian populations.
    Kimura A; Ito-Satoh M; Hayashi T; Takahashi M; Arimura T
    J Cardiol; 2001; 37 Suppl 1():139-46. PubMed ID: 11433818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic cardiomyopathy: etiology, diagnosis, and treatment.
    Ramaraj R
    Cardiol Rev; 2008; 16(4):172-80. PubMed ID: 18562807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restrictive cardiomyopathy.
    Mogensen J; Arbustini E
    Curr Opin Cardiol; 2009 May; 24(3):214-20. PubMed ID: 19593902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.